Related by context. All words. (Click for frequent words.) 61 Interferon alfa 61 antiproliferative effects 60 OvaRex MAb 60 selective inhibition 60 immunoconjugate 59 busulfan 59 TLR9 agonist 59 microtubule inhibitor 59 peptide conjugated 59 Temsirolimus 59 thalidomide Thalomid 59 multikinase inhibitor 59 Aplidin 59 Epirubicin 59 vorinostat 59 Yondelis ® 59 Onconase 59 cytotoxicity assays 59 PORxin TM 59 cyclin dependent kinase inhibitor 58 IgG1 antibody 58 vinca alkaloid 58 targeted antifolate 58 Angiolix 58 YONDELIS R 58 Trabectedin 58 abacavir Ziagen 58 Galectin 58 trabectedin 58 GW# [003] 58 Carfilzomib 58 Cloretazine 58 hepatoma 58 flavopiridol 58 topically administered 58 HSP# inhibitors 58 PD LID 58 Gefitinib 57 humanized monoclonal 57 antisense oligonucleotide 57 thrombin receptor 57 Voreloxin 57 Monoclonal antibody 57 RhuDex R 57 anti CD3 57 depsipeptide 57 orally dosed 57 pancreatic adenocarcinoma 57 MGd 57 TRAIL receptors 57 Hsp# Inhibitor 57 ART# 57 histone deacetylase HDAC inhibitor 57 RhuDex ® 57 sorafenib Nexavar 57 pan HDAC inhibitor 57 ERK signaling 57 Irinotecan 57 DNA intercalator 57 PARP inhibitor 57 PEGylated interferon 57 mertansine 56 vitro cytotoxicity 56 Aurora Kinase 56 Olaparib 56 Cytoxan ® 56 fosbretabulin 56 sCD# 56 AEG# 56 Src inhibitors 56 liposomal formulation 56 Fenretinide 56 Pathway Inhibitor 56 prostate carcinoma 56 VitiGam 56 TransMID TM 56 cidofovir 56 Darinaparsin 56 nucleoside analog 56 Fc fusion protein 56 paclitaxel poliglumex 56 proteasome inhibitor 56 metastatic gastric 56 chimeric monoclonal antibody 56 Pemetrexed 56 antitumoral 56 chemokine receptor 56 Triapine 56 NOD SCID mice 56 Estrogen Receptor 56 Anticalins ® 56 NOD mouse 56 cyclophilin inhibitors 56 homodimers 56 Kahalalide F 56 preclinical efficacy 56 EpCAM 56 BiTE 56 cleavable linker 56 BMS # 56 adenoviral 56 Elvitegravir 56 Cathepsin S 56 mouse xenograft models 56 bispecific antibody 55 Surgical resection 55 receptor tyrosine kinase inhibitor 55 Immunohistochemical analysis 55 Virium 55 FUS1 55 Hematopoietic Stem Cells 55 TIMP 1 55 GRASPA ® 55 demonstrated antitumor activity 55 bevacizumab Avastin ® 55 HIF 1a 55 antimitotic 55 endogenous ligand 55 histone acetyltransferase 55 nucleosides 55 Hematopoietic 55 Sym# 55 idiopathic myelofibrosis 55 Granulocyte Colony Stimulating Factor 55 histone deacetylase inhibitor 55 mda 7 55 YONDELIS 55 radiolabeled 55 Mesenchymal Stem Cells 55 AFFiRiS 55 Interferon alpha 55 pharmacodynamic properties 55 Seliciclib 55 beta 1a 55 cyclophilin D 55 immunotherapeutic vaccine 55 Amrubicin 55 recurrent GBM 55 radionuclide therapy 55 PhG alpha 1 55 Pegylated Interferon 55 inhaled AAT 55 Catenin 55 chemoresistant 55 DermaVir Patch 55 Platinol ® cisplatin 55 Velcade bortezomib 55 targeting CD# 55 relapsing multiple sclerosis 55 PrevOnco 55 metastatic neuroendocrine tumors 55 Apaziquone 55 syngeneic 55 PSMA ADC 55 Squalamine 55 BCG refractory 55 inhibitor RG# 55 ENMD # 55 HQK 55 Cardiotoxicity 55 anti angiogenic agent 55 Tarvacin 55 small molecule activators 55 Xanafide 55 Kinase Inhibitor 55 monoclonal anti 55 monomeric 55 SIR Spheres 55 KSP inhibitor 55 protein tyrosine phosphatase 1B 55 synthetic siRNA 55 gemcitabine carboplatin 55 cytostatic 55 HDAC Inhibitor 55 Annamycin 55 PKC# 55 murine model 55 Pertuzumab 55 uricase 55 Blinatumomab 55 preclinically 55 5 HT4 receptor 55 Allogeneic 55 Alfacell proprietary ribonuclease 54 proteasome inhibitors 54 solubilizing 54 CCR1 54 ZACTIMA 54 histone deacetylase HDAC 54 metastatic bladder 54 CCX# 54 T#I [002] 54 somatostatin analog 54 Butyrate 54 Anticalins R 54 Aviptadil 54 SSc 54 potent cytotoxic 54 humanized monoclonal antibodies 54 Glivec imatinib 54 XYOTAX TM 54 LT NS# 54 HER2 receptor 54 aurora kinase inhibitor 54 Talabostat 54 BAL# [002] 54 murine monoclonal antibody 54 Antiviral Therapy 54 IFN alpha 54 novel prodrug 54 nucleotide analogues 54 radiotherapeutic 54 siRNAs targeting 54 hpSCs 54 Gleevec resistant 54 antisense inhibitor 54 Bosutinib 54 ritonavir boosted 54 mGluR2 NAM 54 chemotherapeutic regimen 54 gefitinib Iressa 54 JAK2 inhibitor 54 interferon beta therapy 54 peptidic 54 SYN# 54 Pgp 54 nucleoside analogues 54 small molecule tyrosine 54 DermaVir 54 ImmuKnow R 54 glycoprotein GP IIb IIIa 54 Natalizumab 54 trastuzumab Herceptin ® 54 Vidaza azacitidine 54 Onrigin 54 Dasatinib 54 Safinamide 54 selective orally bioavailable 54 STEDESA 54 CD#b 54 Reverset 54 Cerashield ™ 54 1α 54 CCR2 54 murine models 54 anti fibrotic 54 Factor VIIa 54 Interferon Beta 54 Clusterin 54 Protease Inhibitors 54 nucleotide analogs 54 EGFR HER2 54 eribulin mesylate 54 CanAg 54 azacytidine 54 cynomolgus monkeys 54 Ocrelizumab 54 aminolevulinic acid 54 EphA2 54 EndoTAGTM 1 54 Eculizumab 54 antiangiogenic agent 54 NeuroVive 54 CTAP# Capsules 54 mGluR5 antagonist 54 Amplimexon 54 Kinase Inhibitors 54 eIF 4E 54 Zybrestat 54 Degarelix 54 Doxil ® 54 selective antagonist 54 Antitumor 54 suppressor gene 54 sodium glucose cotransporter 54 Doxorubicin 54 Leydig cell 54 CCR5 antagonist 54 tacrolimus ointment 54 GV# [001] 54 Tesmilifene 54 Tacrolimus 54 p#NTR 54 acetonide FA 53 glycosylation profile 53 relapsed MM 53 indibulin 53 PDE4 inhibitor 53 Anticalin ® 53 A3 adenosine receptor 53 Symadex 53 huN# DM1 53 gastrointestinal stromal tumors GIST 53 monoclonal antibody MAb 53 MEK1 53 HuMax 53 Daclizumab 53 HepG2 cells 53 microtubule targeting 53 immunomodulatory therapy 53 #D#C# 53 topical formulations 53 pain palliation 53 monoclonal antibody mAb 53 colorectal carcinoma 53 UDCA 53 Inhaled AAT 53 Protein Kinase C 53 protein tyrosine phosphatase 53 decitabine 53 NeuVax 53 recombinant adeno associated 53 irreversible inhibitor 53 recurrent glioblastoma multiforme 53 estrogen estradiol 53 Mutation Analysis 53 heparanase 53 labetuzumab 53 juvenile chondrocytes 53 JVRS 53 metastatic malignant 53 anticancer therapeutics 53 PsA 53 delipidation 53 alefacept 53 tumor antigen 53 Prolongs Survival 53 afamelanotide 53 triphendiol 53 pDNA vaccines 53 Cytochrome P# 53 Bendamustine 53 Pegylated 53 p# biomarker 53 Sanger Sequencing 53 Deforolimus 53 direct thrombin inhibitors 53 vascular disrupting agent 53 pertuzumab 53 ChronVac C R 53 DiLA2 53 EGFR mutation positive 53 basal cell carcinoma BCC 53 Exemestane 53 Zysolin TM 53 deacetylation 53 CEQ# 53 oral JAK1 53 antiproliferative activity 53 cells hESCs 53 Beta catenin pathway 53 metastatic lymph nodes 53 lymphoid cells 53 CCL2 53 p# inhibitor 53 Bucindolol 53 Epidermal Growth Factor Receptor 53 SNCA 53 Cytolin R 53 constitutively expressed 53 TRO# 53 recombinant interferon 53 Pimavanserin 53 Ataluren 53 choroidal neovascularization 53 glycosylated 53 lentiviral vector 53 Progenitor Cells 53 CD4 + CD# 53 antisense inhibitors 53 vivo validation 53 nonsmall cell lung cancer 53 fallopian tube carcinoma 53 cMET 53 essential thrombocythemia ET 53 Adult Stem Cell Therapy 53 EndoTAG TM -1 53 immunostimulatory 53 Medidur ™ FA 53 malignant pleural mesothelioma 53 Polymorphisms 53 hypereosinophilic syndrome 53 Progenitor Cell 53 Diabetic Neuropathy 53 cellular cytotoxicity 53 LHRH 53 Liposomal 53 Phase #b/#a clinical 53 SGLT 53 Bruton tyrosine kinase Btk 53 PPARgamma 53 KRN# 53 E1A 53 ritonavir boosting 53 VNP#M 53 anticancer compound 53 talabostat 53 CaPre TM 53 Aplidin R 53 TÎ ² 4 53 mediated inhibition 53 nucleoside reverse transcriptase inhibitor 52 Protein Kinase 52 administered subcutaneously 52 Thrombin 52 endogenous ligands 52 HepaSphere 52 GLP toxicology studies 52 acinar 52 isotype 52 ovarian carcinoma 52 aberrantly activated 52 Nanobodies 52 Photodynamic therapy 52 humanised monoclonal antibody 52 virus HCV 52 StemEx 52 Sipuleucel T 52 Signaling Pathway 52 Zarnestra 52 physico chemical properties 52 Corgentin 52 fludarabine cyclophosphamide 52 ELISA kit 52 novel histone deacetylase 52 Nilotinib 52 R roscovitine 52 replicase 52 TOP2A 52 VivaGel TM 52 Transdermal Delivery 52 IGFBP2 52 kidney urologic 52 imatinib resistance 52 OHR/AVR# 52 hydroxamic acid 52 Fibroblast 52 synthetic peptides 52 Assay Kits 52 intravesical instillation 52 HMG CoA reductase 52 Rap1 52 mycophenolate mofetil 52 amrubicin 52 radiolabeled monoclonal antibody 52 relapsed leukemia 52 Amarantus 52 ubiquinol 52 stable nucleic acid 52 bispecific 52 Elafin 52 Enzyme Replacement Therapy 52 Decitabine 52 Actimmune ® 52 metastatic colorectal 52 Enzastaurin 52 sargramostim 52 Fulvestrant 52 sunitinib malate 52 Drp1 52 CXCR4 receptor 52 ALK inhibitor 52 NEUGENE antisense 52 IFN α 52 PBMCs 52 cationic lipid 52 IMiDs ® compound 52 Novel Oral 52 substrate specificity 52 somatostatin analogues 52 laparoscopic radical nephrectomy 52 induced phosphorylation 52 CIMZIA ™ 52 cyclase 52 antisense oligonucleotides 52 intratumoral injection 52 Anti Tumor 52 AVI NEUGENE 52 metastatic RCC 52 NPC 1C 52 lymphoid malignancies 52 mTOR inhibitor 52 splice variants 52 erythropoietin receptor 52 lysosomal 52 vidofludimus 52 prognostic biomarker 52 sunitinib Sutent 52 pediatric acute lymphoblastic 52 latanoprost 52 TLK# 52 compound AEZS 52 beta3 52 agonism 52 PI3K inhibitor 52 IFN beta 52 Oasmia 52 A2A receptor 52 bendamustine 52 Adjuvant therapy 52 delafloxacin 52 Hedgehog pathway inhibitor 52 Stat5 52 Akt inhibitor 52 RezularTM 52 Dr. McHutchison 52 histologically confirmed 52 Affymetrix microarray technology 52 JAK#/JAK# 52 novel peptide 52 monocytes macrophages 52 myeloproliferative disorders 52 PARP inhibitors 52 retinoid X 52 efalizumab 52 Antisoma AS# 52 Erythropoietic 51 HLA DRB1 * 51 EZN 51 TLR antagonist 51 Nexavar sorafenib 51 Mutational 51 Macrophage 51 gene polymorphism 51 MAPK signaling pathway 51 null responder 51 RhuDex ™ 51 Gleevec Glivec 51 Mipomersen 51 eIF4E 51 adipose derived regenerative 51 oral dnaJP1 51 p# antigen 51 MT1 MMP 51 dAbs 51 FOLFIRINOX 51 gamma secretase inhibitors 51 Cannabinoid 51 Protease 51 Tyrosine Kinase Inhibitor 51 Aptamer 51 small molecule agonists 51 MVA BN 51 HuLuc# 51 cisplatin gemcitabine 51 RhuDex TM 51 Camptothecin 51 Anticalins 51 urothelial 51 E#F# 51 sGC 51 MEK inhibitor 51 pharmacokinetic characteristics 51 myasthenia gravis MG 51 ESBA# 51 Immunohistochemistry 51 Aromatase 51 paclitaxel Taxol 51 siRNA therapeutics 51 coexpression 51 MET VEGFR2 51 Alocrest 51 IL #E 51 concurrent chemoradiation 51 Omacetaxine 51 PegIFN RBV 51 metastatic renal cell carcinoma 51 BAL# [001] 51 myeloproliferative diseases 51 Soft Tissue Sarcoma 51 salmon calcitonin 51 C1q 51 biologically inactive 51 adult mesenchymal stem 51 Alkaline Phosphatase 51 Neoplasms 51 GHRH 51 Interferon Gamma 51 nicotinic acetylcholine receptor 51 StemEx R 51 Nucleotide 51 KNS # 51 samalizumab 51 novel oral anticoagulant 51 Delcath Phase III 51 annexin V 51 papillary renal cell carcinoma 51 relapsed ovarian cancer 51 pancreatic ductal 51 CC genotype 51 selective kinase inhibitor 51 Histone 51 NRTI resistance 51 soluble receptor 51 pharmacodynamic profiles 51 stem cell transplantations 51 IKK epsilon 51 Glypromate 51 Proteasome 51 vinblastine 51 undifferentiated hESCs 51 haematological cancers 51 Diabetic Foot Ulcer 51 p# MAPK 51 quinolone 51 CTLs 51 AKT inhibitor 51 BMS# 51 recombinant antibodies 51 Conjugates 51 CALGB 51 Alemtuzumab 51 Septin9 51 sd rxRNA 51 Cloretazine ® 51 Tumor Microenvironment 51 anti miRs 51 prodrugs 51 protein tyrosine phosphatases 51 SCCHN 51 Candesartan 51 Chemokine Receptor 51 Galectin 3 51 kinase assay 51 viral kinetics 51 p# Shc 51 PI3K/mTOR 51 ISEL 51 intravenous AAT 51 synovial fibroblasts 51 curative therapy 51 Sorafenib 51 5 HT2C receptor 51 AChE inhibitors 51 Nicotinic 51 Cytolin ® 51 NKG2D 51 GSK '# 51 telomerase inhibitor 51 CEVEC 51 aminotransferase 51 CG# [003] 51 Tigecycline 51 small molecule chemotherapeutic 51 ARRY # 51 druggable 51 selective adenosine 51 sipuleucel T 51 Cytotoxic T 51 rxRNA 51 Systemic Sclerosis 51 AtherOx 51 thymidylate synthase TS 51 insulin sensitizers 51 B7 H4 51 Chronic lymphocytic leukemia 51 chronic myocardial ischemia 51 bioabsorbable polymer 51 osteoblast 51 clade B 51 Plenaxis TM 51 ISF# 51 IFN Beta CTP 51 benzimidazole 51 tkRNAi technology 51 PSN# [001] 51 malignant prostate 51 Monoclonal Antibody 51 aurora kinase 51 Janus kinase 51 NFAT 51 neoadjuvant treatment 51 Qdot 51 Universal Flu Vaccine 51 recurrent NSCLC 51 Advanced Renal Cell 51 CTEPH 51 engineered anticoagulant 51 nicotinic receptor 51 pomalidomide 51 Tumor Necrosis Factor 51 immunoregulation 51 chemoresistance 51 schizophrenia CIAS 51 PDE# inhibitors 51 protein tyrosine kinase 51 Febuxostat 51 hepatitis C HCV 51 NFkB 51 castrate resistant prostate cancer 51 GRNVAC1 51 Specifid 51 MDACC 51 alpha antagonist 51 RNA antagonist 51 A1PI 51 Chemokine 51 renal tumors 51 MGUS 51 trodusquemine 51 gemcitabine Gemzar ® 51 neoplastic diseases 51 tipranavir 51 TLR8 51 Vitro Activity 51 ZFN 51 SHPT 51 Modrenal 51 Beta Amyloid 51 Fc receptor 51 Immune Therapy 51 peroxisomal 51 Erbitux cetuximab 51 angiogenesis inhibition 51 JAK1 51 ProLindac TM 51 renin inhibitor 51 PKC isoforms 51 acadesine 51 JAK2 inhibitors 51 drug zotarolimus 51 Ispinesib 51 radiolabeling 51 Homeostasis 51 c KIT 50 pancreatic neuroendocrine tumors 50 ISTODAX 50 Myelodysplastic Syndrome MDS 50 Bremelanotide 50 TEMODAL 50 NK1 50 Axenohl 50 vismodegib 50 cell lymphoma CTCL 50 COL#A# 50 lymphocyte counts 50 Tyrosine Kinase Inhibitors 50 Neuropeptide Y 50 cyclic peptide 50 Cytotoxicity 50 transgenic mouse models 50 nonmetastatic 50 verteporfin 50 teriflunomide 50 CRLX# 50 Thiovir 50 enzyme inhibitors 50 CCR5 inhibitor 50 lymphoproliferative disorders 50 Mucosal 50 Replacement Therapy 50 NMDA antagonists 50 pancreatic islet cell 50 C#T [002] 50 epithelial barrier 50 Sezary syndrome 50 cytotoxics 50 anti CD3 antibody 50 OX1 50 canakinumab 50 DLC1 50 panobinostat 50 Antisense 50 virosome 50 clinicopathological 50 metastatic malignant melanoma 50 Enhanze Technology 50 peptide antigens 50 unoprostone isopropyl 50 lesional 50 IGF 1R inhibitor 50 Prolor 50 Dalbavancin 50 ceftazidime 50 miRview TM mets 50 Fresenius Biotech 50 PEG SN# 50 systemic RNAi therapeutic 50 MAb 50 potent inhibitor 50 Btk inhibitor 50 Hepsera adefovir dipivoxil 50 ATD Gel 50 patientswith 50 Polymerase 50 N Myc 50 BCIRG 50 Inhalation Solution 50 Talotrexin 50 Angiotensin II 50 haematologic malignancies 50 BLP# Liposome Vaccine 50 lorvotuzumab mertansine 50 Li Fraumeni Syndrome 50 Vascugel 50 Apoptone 50 Telatinib 50 Nexavar tablets 50 potently inhibit 50 Exelixis XL# 50 sJIA 50 gag pol 50 MORAb 50 buccal spray 50 tumor specific antigen 50 OvaDx 50 stated Michelle Berrey 50 HepDirect technology 50 familial amyloidotic polyneuropathy FAP 50 alfa interferon 50 metastatic pancreatic 50 amine oxidase 50 favorable pharmacokinetic profile 50 choroidal vasculopathy 50 darinaparsin ZIO 50 telomerase activator 50 anti CD# antibodies 50 microtubule associated 50 Prodrug 50 anti angiogenic therapy 50 HBV vaccine 50 #:#-# [031] 50 UPLYSO 50 RAV# 50 Wnt signaling pathway 50 IgM antibody 50 HIF PHI 50 TLR8 agonist 50 Potent Inhibitor 50 QOPI 50 multiple myeloma MM 50 colorectal liver metastases 50 SUTENT ® 50 PKC enzyme 50 Canvaxin TM 50 interferon gamma 1b 50 PNT# 50 miRview ™ squamous 50 SOX9 50 novel immunotherapeutic 50 transdermally 50 Transcription Factor 50 polyclonal antibody 50 lysophosphatidic acid LPA 50 Locked Nucleic Acid LNA 50 NSCLC tumors 50 Eluting Stent 50 genomic biomarker 50 dexpramipexole 50 GelSite polymer 50 Liprostin 50 Systemic Delivery 50 lexidronam injection 50 MabCampath 50 Cerashield 50 ChronVac C ® 50 Neuroprotection 50 HER2 ErbB2 50 Cellular Immunotherapy 50 MELAS 50 heterodimers 50 transcriptional activation 50 Micromet BiTE 50 Antiangiogenic 50 Taxanes 50 tyrosine phosphorylation 50 lymphoblastoid cell lines 50 PathHunter 50 Proxinium TM 50 Metastatic breast cancer 50 ProAlgaZyme 50 NN# [001] 50 Parathyroid Hormone 50 FVIIa 50 Kamada AAT 50 BiTE Antibody 50 prostone 50 IRESSA 50 plerixafor 50 Dystrophin 50 vWD 50 BAY #-# 50 histocompatibility 50 morpholino 50 proapoptotic 50 Preclinical Study 50 Cytotoxic 50 Oligonucleotide 50 ACEI 50 BrachySil 50 Certican 50 GlcNAc 50 Rotigotine 50 ATIR 50 embryonic stem cells ESCs 50 prostate adenocarcinoma 50 CHD5 50 Telbivudine 50 Denufosol 50 Ceflatonin R 50 neoplastic transformation 50 cathepsin B 50 Cutaneous T 50 allogeneic bone marrow 50 INCB# [003] 50 homodimer 49 immatics 49 Trandolapril 49 Multiple Ascending Dose 49 Presents Preclinical Data 49 renin inhibitors 49 EGFR inhibition 49 Ampligen r 49 HuMax CD# 49 NF KB 49 Papillary 49 stage IIIb IV 49 GammaCan 49 interferon lozenges 49 Mass Spectrometry MS 49 heterologous 49 MTHFR gene 49 atypical Hemolytic Uremic Syndrome 49 fusion inhibitor 49 Allovectin 7 49 Phase Ib study 49 CVac 49 malignant lymphomas 49 Guanilib 49 BCL2 49 NS5A 49 Placebo Controlled Trial 49 refractory colorectal cancer 49 vitamin D analogs 49 tocilizumab 49 Bruton tyrosine kinase 49 RNase L 49 microdose 49 antifolates 49 thyroid hormone receptor 49 glucosamine HCl 49 INSPIRE Trial Phase III 49 myelofibrosis polycythemia vera 49 FGFR4 49 Novel Therapeutic 49 OXIGON TM 49 fibrotic disease 49 NS4B 49 hybridoma 49 Tumor Response 49 virosome technology 49 Modulates 49 Phase 2a Clinical Trial 49 CCR5 mAb 49 subcutaneous formulation 49 lysate 49 JUVISTA R Human 49 GSK# [001] 49 retroviral vectors 49 reversible inhibitors 49 Xinlay 49 epothilones 49 leukemia AML 49 allogeneic hematopoietic stem cell 49 JAK2 Inhibitor 49 evaluating tivozanib 49 oral renin inhibitor 49 Phase III randomized controlled 49 Valopicitabine 49 RAPAFLO R 49 Locked Nucleic Acid 49 Phase 2b Clinical Trial 49 Protease Inhibitor 49 Solorel TM 49 therapeutically relevant 49 Solesta 49 CHAMPION PCI 49 Immunomodulatory 49 Interferon Alpha 49 Hypertriglyceridemia 49 lumiliximab 49 pramlintide metreleptin combination 49 NEUGENE 49 Pitavastatin 49 Chronic Fatigue Syndrome CFS 49 MAbs 49 catenin 49 miRagen 49 AZT 3TC 49 c Myb 49 CIMZIA TM certolizumab pegol 49 adipogenesis 49 PSN# [002] 49 Anticancer Agents 49 Etravirine 49 envelope glycoprotein 49 Mantle Cell Lymphoma 49 epoetin alpha 49 CSPG